Rubenstein David M. 4
4 · Moderna, Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Rubenstein David M.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-04-30+677→ 677 total - Exercise/Conversion
Restricted Stock Units
2025-04-30−677→ 0 total→ Common Stock (677 underlying) - Award
Restricted Stock Units
2025-04-30+8,116→ 8,116 total→ Common Stock (8,116 underlying) - Award
Stock Option (Right to Buy)
2025-04-30+12,756→ 12,756 totalExercise: $28.54Exp: 2035-04-30→ Common Stock (12,756 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The shares subject to this restricted stock unit award vested in full on April 30, 2025.
- [F3]This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
- [F4]The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.